MedPath

HUNILIFE BIOTECHNOLOGY, INC.

HUNILIFE BIOTECHNOLOGY, INC. logo
🇹🇼Taiwan
Ownership
Private
Established
2012-11-21
Employees
11
Market Cap
-
Website
http://www.hunilife.com

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

A Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Immunogenicity of HuL001

Phase 1
Recruiting
Conditions
Idiopathic Pulmonary Fibrosis
Interventions
First Posted Date
2020-09-07
Last Posted Date
2023-03-09
Lead Sponsor
HuniLife Biotechnology, Inc.
Target Recruit Count
24
Registration Number
NCT04540770
Locations
🇨🇳

Mackay Memorial Hospital, New Taipei City, Taiwan

🇨🇳

National Taiwan University Hospital, Taipei, Taiwan

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.